Wells Fargo Maintains an 'Outperform' on athenahealth (ATHN); Triple-Barrel Deal Significantly Improves Visibility
Tweet Send to a FriendGet Alerts ATHN Hot Sheet
Price: $86.37 +1.03%
Rating Summary:
7 Buy, 12 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
7 Buy, 12 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade ATHN Now!
Wells Fargo maintains an 'Outperform' on athenahealth (NASDAQ: ATHN).
Analyst, Jamie Stockton, said, "athenahealth announced a triple-barrel deal with HMA this morning for about 900 physicians and 300 NPs/PAs. We expect most of the implementations to hit the ''doc add'' numbers in the first half of 2013, improving visibility significantly for the 2013 enterprise contribution. Quality Systems (Nasdaq: QSII) is losing HMA."
For an analyst ratings summary and ratings history on athenahealth click here. For more ratings news on athenahealth click here.
Shares of athenahealth closed at $79.16 yesterday, with a 52 week range of $40.79-$87.16.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Jamie Stockton, said, "athenahealth announced a triple-barrel deal with HMA this morning for about 900 physicians and 300 NPs/PAs. We expect most of the implementations to hit the ''doc add'' numbers in the first half of 2013, improving visibility significantly for the 2013 enterprise contribution. Quality Systems (Nasdaq: QSII) is losing HMA."
For an analyst ratings summary and ratings history on athenahealth click here. For more ratings news on athenahealth click here.
Shares of athenahealth closed at $79.16 yesterday, with a 52 week range of $40.79-$87.16.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- Topeka Capital Sees Attractive Entry in Ducommun (DCO); Starts at Buy
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Wells FargoLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

